Emmanouil Metzakopian

Emmanouil Metzakopian is CEO and co-founder of CellCodex, a Cambridge drug discovery company combining frontier AI with human cell models to select drug targets, with programmes in Parkinson's disease and hepatotoxicity. Previously CSO at bit.bio, he led scientific strategy across human cell product, cell therapy and pharma partnerships. Before that he was a group leader at the UK Dementia Research Institute focusing on therapeutic targets for Parkinson's disease and dementia.